BIBN 4096
Tocris Bioscience, part of Bio-Techne | Catalog # 4561
Potent and selective CGRP antagonist
Key Product Details
Description
Potent and selective CGRP antagonist
Alternative Names
Olcegepant
Product Description
BIBN 4096 is a potent and selective CGRP receptor antagonist (IC50 values are 0.03 and 6.4 nM for human and rat CGRP receptors respectively). Displays high affinity for human CGRP receptors (Ki = 14.4 pM); exhibits no significant affinity for 75 other receptors. BIBN 4096 improves pain symptoms in a mouse migraine model.Product Specifications
Molecular Weight
869.65
Formula
C38H47Br2N9O5
Storage
Store at -20°C
Purity
≥95% (HPLC)
Chemical Name
1-[3,5-Dibromo-N-[[4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-1-piperidinyl]carbonyl]-D-tyrosyl-L-lysyl]-4-(4-pyridinyl)-piperazine
CAS Number
204697-65-4
PubChem ID
6918509
InChI Key
ITIXDWVDFFXNEG-JHOUSYSJSA-N
SMILES
O=C(N[C@H](CC4=CC(Br)=C(O)C(Br)=C4)C(N[C@@H](CCCCN)C(N5CCN(C6=CC=NC=C6)CC5)=O)=O)N(CC3)CCC3N2CC1=CC=CC=C1NC2=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| 2eq.HCl | 43.48 | 50 | |
| DMSO | 43.48 | 50 |
Preparing Stock Solutions
for BIBN 4096
The following data is based on the product molecular weight 869.65
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 2.30 mL | 11.50 mL | 23.00 mL |
| 2.5 mM | 0.46 mL | 2.30 mL | 4.60 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.30 mL |
| 25 mM | 0.05 mL | 0.23 mL | 0.46 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Rudolf Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-[N2-[3,5-Dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1- piperidinyl J.Med.Chem. 2005 PMID: 16161996
- Prado TREK channel activation suppresses migraine pain phenotype. iScience 2021 PMID: 34458705
- Doods Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br.J.Pharmacol. 2000 PMID: 10711339
Product Specific Notices for BIBN 4096
For research use only
Loading...
Loading...